Skip to main content
SpringerLink
Log in

Embracing Digital Technologies in the Pharmaceutical Industry

  • Chapter
  • First Online:
Control Engineering in Mechatronics

Part of the book series: Emerging Trends in Mechatronics ((emerg. Trends in Mechatronics))

Abstract

The pharmaceutical sector is vital to the healthcare system. Without it, drug discovery, development, and distribution would be impossible. When we say “the pharmaceutical industry, “we refer to research, development, and distribution. Pharmaceutical and healthcare companies are under great pressure to innovate via research and development and to stay compliant at all costs considering recent technological advancements. Unfortunately, this pressure negatively impacts the effectiveness of clinical trials, operational efficiency, sales, and ultimately the development of this sector. Utilizing digital technology may provide substantial benefits for the global pharmaceutical industry. In this book chapter, we are reviewing the digital technologies that affect the productivity of the pharmaceutical industry.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Paul SM, Mytelka DS, Dunwiddie CT, Persinger CC, Munos BH, Lindborg SR, Schacht AL (2010) How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov 9(3):203–214

    Google Scholar 

  2. Deore AB, Dhumane JR, Wagh R, Sonawane R (2019) The stages of drug discovery and development process. Asian J Pharm Res Dev 7(6):62–67

    Google Scholar 

  3. Schweitzer SO, Lu ZJ (2018) Pharmaceutical economics and policy: perspectives, promises, and problems. Oxford University Press

    Google Scholar 

  4. Laurenza E, Quintano M, Schiavone F, Vrontis D (2018) The effect of digital technologies adoption in healthcare industry: a case based analysis. Bus Process Manag J 24(5):1124–1144

    Google Scholar 

  5. Tiwary A, Mahato M, Chidar A, Chandrol MK, Shrivastava M, Tripathi M (2018) Internet of Things (IoT): research, architectures and applications. Int J Future Revolution Comput Sci Commun Eng 4(3):23–27

    Google Scholar 

  6. An IoT ecosystem consists of web-enabled smart devices that use embedded systems such as processors, sensors, and communication gear to gather, transmit, and act upon data from their surroundings

    Google Scholar 

  7. Tawalbeh LA, Muheidat F, Tawalbeh M, Quwaider M, Abd El-Latif AA (2022) Edge enabled IoT system model for secure healthcare. Measurement 191:110792

    Google Scholar 

  8. Barenji RV, Barenji AV, Hashemipour M (2014) A multi-agent RFID-enabled distributed control system for a flexible manufacturing shop. Int J Adv Manuf Technol 71:1773–1791

    Google Scholar 

  9. Sharma A, Kaur J, Singh I (2020) Internet of things (IoT) in pharmaceutical manufacturing, warehousing, and supply chain management. SN Comput Sci 1:1–10

    Google Scholar 

  10. Ahmadi V, Benjelloun S, El Kik M, Sharma T, Chi H, Zhou W (2020) Drug governance: IoT-based blockchain implementation in the pharmaceutical supply chain. In: 2020 sixth international conference on mobile and secure services (MobiSecServ), pp 1–8. IEEE

    Google Scholar 

  11. Badulescu Y, Tiwari MK, Cheikhrouhou N (2022) MCDM approach to select IoT devices for the reverse logistics process in the Clinical Trials supply chain. IFAC-PapersOnLine 55(10):43–48

    Google Scholar 

  12. Singh M, Sachan S, Singh A, Singh KK (2020) Internet of Things in pharma industry: possibilities and challenges. In: Emergence of pharmaceutical industry growth with industrial IoT approach, pp 195–216

    Google Scholar 

  13. Sharma DK, Kaur G, Sharma M (2021) An industrial internet of things approach for pharmaceutical industry growth. In: Further advances in internet of things in biomedical and cyber physical systems, pp 289–309

    Google Scholar 

  14. Rashid A, Chaturvedi A (2019) Cloud computing characteristics and services: a brief review. Int J Comput Sci Eng 7(2):421–426

    Google Scholar 

  15. Attaran M, Woods J (2019) Cloud computing technology: improving small business performance using the Internet. J Small Bus Entrep 31(6):495–519

    Google Scholar 

  16. Namasudra S (2021) Data access control in the cloud computing environment for bioinformatics. Int J Appl Res Bioinform (IJARB) 11(1):40–50

    Google Scholar 

  17. Cai F, Zhu N, He J, Mu P, Li W, Yu Y (2019) Survey of access control models and technologies for cloud computing. Clust Comput 22:6111–6122

    Google Scholar 

  18. Alouffi B, Hasnain M, Alharbi A, Alosaimi W, Alyami H, Ayaz M (2021) A systematic literature review on cloud computing security: threats and mitigation strategies. IEEE Access 9:57792–57807

    Google Scholar 

  19. Dang LM, Piran MJ, Han D, Min K, Moon H (2019) A survey on internet of things and cloud computing for healthcare. Electronics 8(7):768

    Google Scholar 

  20. Hariry RE, Barenji RV, Paradkar A (2020) From Industry 4.0 to Pharma 4.0. In: Handbook of smart materials, technologies, and devices: applications of industry 4.0, pp 1–22

    Google Scholar 

  21. Sun L, Jiang X, Ren H, Guo Y (2020) Edge-cloud computing and artificial intelligence in internet of medical things: architecture, technology and application. IEEE Access 8:101079–101092

    Google Scholar 

  22. Priporas CV, Vellore-Nagarajan D (2022) New-normal market entry mode for pharmaceuticals: an internet of things (IoT) market entry framework stemming from COVID-19. Int Market Rev (ahead-of-print)

    Google Scholar 

  23. Singh S, Sundram S, Malviya R, Sekar M (2023) Drug development using cloud application. In: Bioinformatics tools and big data analytics for patient care, pp. 159–180. Chapman and Hall/CRC

    Google Scholar 

  24. Noonan T, Denzinger K, Talagayev V, Chen Y, Puls K, Wolf CA, Wolber G, et al (2022) Mind the gap—deciphering GPCR pharmacology using 3D pharmacophores and artificial intelligence. Pharmaceuticals 15(11):1304

    Google Scholar 

  25. Gateau T, Ayaz H, Dehais F (2018) In silico vs. over the clouds: on-the-fly mental state estimation of aircraft pilots, using a functional near infrared spectroscopy based passive-BCI. Front Hum Neurosci 12:187

    Google Scholar 

  26. Hulsen T, Jamuar SS, Moody AR, Karnes JH, Varga O, Hedensted S, McKinney EF, et al (2019) From big data to precision medicine. Front Med 34

    Google Scholar 

  27. Agbehadji IE, Awuzie BO, Ngowi AB, Millham RC (2020) Review of big data analytics, artificial intelligence and nature-inspired computing models towards accurate detection of COVID-19 pandemic cases and contact tracing. Int J Environ Res Public Health 17(15):5330

    Google Scholar 

  28. Hariri RH, Fredericks EM, Bowers KM (2019) Uncertainty in big data analytics: survey, opportunities, and challenges. J Big Data 6(1):1–16

    Google Scholar 

  29. Hamilton S (2021) Real-time big data analytics, sustainable Industry 4.0 wireless networks, and Internet of Things-based decision support systems in cyber-physical smart manufacturing. Econ Manag Financ Markets 16(2):84–94

    Google Scholar 

  30. Shahbaz M, Gao C, Zhai L, Shahzad F, Luqman A, Zahid R (2021) Impact of big data analytics on sales performance in pharmaceutical organizations: the role of customer relationship management capabilities. PLoS ONE 16(4):e0250229

    Google Scholar 

  31. Hariry RE, Barenji RV, Paradkar A (2022) Towards Pharma 4.0 in clinical trials: a future-orientated perspective. Drug Discovery Today 27(1):315–325

    Google Scholar 

  32. Vatankhah Barenji R (2022) A blockchain technology based trust system for cloud manufacturing. J Intell Manuf 33(5):1451–1465

    Google Scholar 

  33. Saadati Z, Zeki CP, Vatankhah Barenji R (2021) On the development of blockchain-based learning management system as a metacognitive tool to support self-regulation learning in online higher education. Interact Learn Environ 1–24

    Google Scholar 

  34. Ghadge A, Bourlakis M, Kamble S, Seuring S (2022). Blockchain implementation in pharmaceutical supply chains: a review and conceptual framework. Int J Prod Res 1–19

    Google Scholar 

  35. Uddin M (2021) Blockchain Medledger: Hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry. Int J Pharm 597:120235

    Google Scholar 

  36. Haleem A, Javaid M, Singh RP, Suman R (2021) Telemedicine for healthcare: capabilities, features, barriers, and applications. Sens Int 2:100117

    Google Scholar 

  37. Li JPO, Liu H, Ting DS, Jeon S, Chan RP, Kim JE, Ting DS, et al (2021) Digital technology, tele-medicine and artificial intelligence in ophthalmology: a global perspective. Prog Retinal Eye Res 82:100900

    Google Scholar 

  38. Kaplan B (2020) Revisiting health information technology ethical, legal, and social issues and evaluation: telehealth/telemedicine and COVID-19. Int J Med Inform 143:104239

    Google Scholar 

  39. Unni EJ, Patel K, Beazer IR, Hung M (2021) Telepharmacy during COVID-19: a scoping review. Pharmacy 9(4):183

    Google Scholar 

  40. Vrontis D, Christofi M, Pereira V, Tarba S, Makrides A, Trichina E (2022) Artificial intelligence, robotics, advanced technologies and human resource management: a systematic review. Int J Hum Resour Manage 33(6):1237–1266

    Google Scholar 

  41. Fjelland R (2020) Why general artificial intelligence will not be realized. Humanit Soc Sci Commun 7(1):1–9

    Google Scholar 

  42. Ahuja AS (2019) The impact of artificial intelligence in medicine on the future role of the physician. Peer J 7:e7702

    Google Scholar 

  43. Paul D, Sanap G, Shenoy S, Kalyane D, Kalia K, Tekade RK (2021) Artificial intelligence in drug discovery and development. Drug Discovery Today 26(1):80

    Google Scholar 

  44. Barenji RV, Akdag Y, Yet B, Oner L (2019) Cyber-physical-based PAT (CPbPAT) framework for Pharma 4.0. Int J Pharm 567:118445

    Google Scholar 

  45. Chan HS, Shan H, Dahoun T, Vogel H, Yuan S (2019) Advancing drug discovery via artificial intelligence. Trends Pharmacol Sci 40(8):592–604

    Google Scholar 

  46. Kaul V, Enslin S, Gross SA (2020) History of artificial intelligence in medicine. Gastrointest Endosc 92(4):807–812

    Google Scholar 

  47. Gamberini L, Pluchino P, Porto L, Zordan F, Monterosso A, Palanivel K, Fontanari A (2021) Patchai: an e-health application powered by an AI virtual assistant to support patients in their clinical trials. In: HCI international 2021-posters: 23rd HCI international conference, HCII 2021, virtual event, July 24–29, 2021, proceedings, Part III 23, pp 315–322. Springer International Publishing

    Google Scholar 

  48. Noorbakhsh-Sabet N, Zand R, Zhang Y, Abedi V (2019) Artificial intelligence transforms the future of health care. Am J Med 132(7):795–801

    Google Scholar 

  49. Adam G, Rampášek L, Safikhani Z, Smirnov P, Haibe-Kains B, Goldenberg A (2020) Machine learning approaches to drug response prediction: challenges and recent progress. NPJ Precis Oncol 4(1):19

    Google Scholar 

  50. Zhavoronkov A (2018) Artificial intelligence for drug discovery, biomarker development, and generation of novel chemistry. Mol Pharm 15(10):4311–4313

    Google Scholar 

  51. Woo M (2019) An AI boost for clinical trials. Nature 573(7775):S100–S100

    Google Scholar 

  52. Harrer S, Shah P, Antony B, Hu J (2019) Artificial intelligence for clinical trial design. Trends Pharmacol Sci 40(8):577–591

    Google Scholar 

  53. Bansal A, Padappayil RP, Garg C, Singal A, Gupta M, Klein A (2020) Utility of artificial intelligence amidst the COVID 19 pandemic: a review. J Med Syst 44:1–6

    Google Scholar 

  54. Racine E, Boehlen W, Sample M (2019) Healthcare uses of artificial intelligence: challenges and opportunities for growth. In: Healthcare management forum, vol 32, no 5, pp 272–275). SAGE Publications, CA, Los Angeles

    Google Scholar 

  55. Dash R, McMurtrey M, Rebman C, Kar UK (2019) Application of artificial intelligence in automation of supply chain management. J Strateg Innov Sustain 14(3):43–53

    Google Scholar 

  56. Kulkov I (2021) The role of artificial intelligence in business transformation: a case of pharmaceutical companies. Technol Soc 66:101629

    Google Scholar 

  57. Mück JE, Ünal B, Butt H, Yetisen AK (2019) Market and patent analyses of wearables in medicine. Trends Biotechnol 37(6):563–566

    Google Scholar 

  58. Lu L, Zhang J, Xie Y, Gao F, Xu S, Wu X, Ye Z (2020) Wearable health devices in health care: narrative systematic review. JMIR mHealth uHealth 8(11):e18907

    Google Scholar 

  59. DeVore AD, Wosik J, Hernandez AF (2019) The future of wearables in heart failure patients. JACC Heart Fail 7(11):922–932

    Google Scholar 

  60. Saadati Z, Barenji RV (2022) Toward Industry 5.0: cognitive cyber-physical system. In: Industry 4.0: technologies, applications, and challenges, pp 257–268. Springer Nature Singapore, Singapore

    Google Scholar 

  61. Yaacoub JPA, Salman O, Noura HN, Kaaniche N, Chehab A, Malli M (2020) Cyber-physical systems security: limitations, issues and future trends. Microprocess Microsyst 77:103201

    Google Scholar 

  62. Qiu H, Qiu M, Liu M, Memmi G (2020) Secure health data sharing for medical cyber-physical systems for the healthcare 4.0. IEEE J Biomed Health Inform 24(9):2499–2505

    Google Scholar 

  63. Sharma A, Rathee G, Kumar R, Saini H, Varadarajan V, Nam Y, Chilamkurti N (2019) A secure, energy-and sla-efficient (sese) e-healthcare framework for quickest data transmission using cyber-physical system. Sensors 19(9):2119

    Google Scholar 

  64. Wang S, Wang H, Li J, Wang H, Chaudhry J, Alazab M, Song H (2020) A fast CP-ABE system for cyber-physical security and privacy in mobile healthcare network. IEEE Trans Ind Appl 56(4):4467–4477

    Google Scholar 

  65. Hussain I, Park SJ (2021) Big-ECG: cardiographic predictive cyber-physical system for stroke management. IEEE Access 9:123146–123164

    Google Scholar 

  66. Vangipuram SL, Mohanty SP, Kougianos E (2021) CoviChain: a blockchain based framework for nonrepudiable contact tracing in healthcare cyber-physical systems during pandemic outbreaks. SN Comput Sci 2:1–16

    Google Scholar 

  67. Steinwandter V, Borchert D, Herwig C (2019) Data science tools and applications on the way to Pharma 4.0. Drug Discovery Today 24(9):1795–1805

    Google Scholar 

  68. Arden NS, Fisher AC, Tyner K, Lawrence XY, Lee SL, Kopcha M (2021) Industry 4.0 for pharmaceutical manufacturing: preparing for the smart factories of the future. Int J Pharm 602:120554

    Google Scholar 

  69. Hariry RE, Barenji RV, Azizi A (2022) Toward Pharma 4.0 in drug discovery. In: Industry 4.0: technologies, applications, and challenges, pp 221–238. Springer Nature Singapore, Singapore

    Google Scholar 

  70. Reinhardt IC, Oliveira JC, Ring DT (2020) Current perspectives on the development of industry 4.0 in the pharmaceutical sector. J Ind Inf Integr 18:100131

    Google Scholar 

  71. Kumar SH, Talasila D, Gowrav MP, Gangadharappa HV (2020) Adaptations of Pharma 4.0 from Industry 4.0. Drug Invention Today 14(3)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Health Technology, Faculty of Pharmacy, Girne American University, Kyrenia, Cyprus

    Reza Ebrahimi Hariry

  2. Department of Engineering, School of Science and Technology, Nottingham Trent University, Nottingham, NG11 8NS, UK

    Reza Vatankhah Barenji

Authors
  1. Reza Ebrahimi Hariry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reza Vatankhah Barenji
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reza Ebrahimi Hariry .

Editor information

Editors and Affiliations

  1. School of Engineering, Computing and Mathematics, Oxford Brookes University, Wheatley Campus, Oxford, UK

    Aydin Azizi

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Hariry, R.E., Barenji, R.V. (2023). Embracing Digital Technologies in the Pharmaceutical Industry. In: Azizi, A. (eds) Control Engineering in Mechatronics. Emerging Trends in Mechatronics. Springer, Singapore. https://doi.org/10.1007/978-981-16-7775-5_4

Download citation

Publish with us

Policies and ethics

Search

Navigation